Lirametostat (CPI-1205)

Ask supplier a question | View on supplier's website

Lirametostat (CPI-1205) is an orally available selective inhibitor of the histone lysine methyltransferase EZH2 with IC50 values of 2 nM and 52 nM for EZH2 and EZH1 respectively. It has potential antineoplastic activity.

Supplier	Selleck Chemicals
Product #	S8353
Sku #	S8353-10mM/1mL
Pricing	10mM/1mL, $487.00

Citations for this product:

Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling

Alison A. Chomiak, et al., bioRxiv - Cancer Biology 2023

Quote: ... CPI- 1205 (Selleck Chemicals S8353) EPZ0011989 (Selleck Chemicals S7805) ...

Feedback